Plasma (physics)

Luna Innovations Retains Industry Veterans to Lead Strategy, Operations and Finance

Retrieved on: 
Wednesday, May 1, 2024
Technology, Nanotechnology, Telecommunications, Software, Networks, Hardware, Cloud, Doctor of Philosophy, Electrical engineering, Corporation, Sale, University, CFO, Physics, Danaher Corporation, St. Cloud State University, Cirrus Logic, Accounting, Commerce, Princeton University, PwC, Plasma (physics), National Instruments, Employment, Minnesota State University, Mankato, Consultant, Strategic planning, Comment, ESI Group, Emerson Electric, Senior, Interim, Keysight, University College Dublin, Committee, Honeywell, Management

Luna Innovations Incorporated (NASDAQ: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that it has retained senior executives and industry veterans Alex Davern and Kevin Ilcisin as consultants to provide strategic advice and counsel with respect to the Company’s operations and strategy.

Key Points: 
  • Luna Innovations Incorporated (NASDAQ: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that it has retained senior executives and industry veterans Alex Davern and Kevin Ilcisin as consultants to provide strategic advice and counsel with respect to the Company’s operations and strategy.
  • Mr. Davern and Mr. Ilcisin will report to Richard Roedel, the Company’s Interim Executive Chairman and Interim President.
  • Mr. Davern and Mr. Ilcisin will play a leading role in the strategic review process and will begin their work with a full review of Luna’s operations and strategy.
  • There is also no assurance as to the specific terms or timing for any agreed transaction if one were to result.

Recce Pharmaceuticals Achieves Positive Phase I Clinical Trial Data of RECCE® 327 as an Intravenous Infusion Formulation

Retrieved on: 
Thursday, July 20, 2023
Volunteering, Male, Regulation of therapeutic goods, Urinary tract infection, UTI, Respiratory rate, Infection, Kidney failure, Pharmacokinetics, ECG, PEG, Therapeutic Goods Administration, ASX, Escherichia coli, FSE, Toxicity, ATCC, Kidney, Gram-negative bacteria, Female, Sepsis, Șaeș, Thermoregulation, Death, Vital signs, MD, Patient, Bacteria, Heart rate, Health, Plasma (physics), Monitoring, Safety, RCE, Medical imaging, Pharmaceutical industry, Dietary supplement, Medical device, Phosphorus, Urine, Plasma

SYDNEY Australia, July 20, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced positive results from a Phase I (R327-001) study of RECCE® 327 (R327) as an intravenous (IV) infusion formulation in 80 healthy male subjects.

Key Points: 
  • We look forward to building off these results by initiating a Phase II study in patients with early-stage sepsis.
  • A total of 80 subjects were randomized in eight single-dose cohorts, and 60 subjects received R327, with 20 receiving placebo.
  • Enrolled subjects completed dosing per the protocol and completed the trial without dosing interruptions.
  • The Company is currently conducting a Phase I/II UTI clinical trial evaluating R327 IV at faster infusion rates – recently announcing its first cohort dosed, including its first female subject.

Adtec Healthcare Limited, a leading Cold Plasma medical device manufacturer, spins out from Adtec Europe Ltd

Retrieved on: 
Thursday, June 1, 2023
CE, Wound, Infection, Collection, Plasma, Plasma (physics), Japan, FDA, Pharmaceutical industry

LONDON, June 1, 2023 /PRNewswire/ -- Adtec Healthcare Limited, originally part of the European subsidiary of its parent company Adtec Technology Japan, was the first company worldwide to introduce Cold Plasma on wounds in clinical trials. It is a leading technology delivering a pioneering treatment for chronic and infected wounds, with strong antibacterial properties and no side effects. Adtec Healthcare's demonstration of the strong clinical benefit of microwave-powered Cold Plasma for the management of infections in chronic wounds, has paved the way for further Cold Plasma research on additional clinical applications.

Key Points: 
  • A renowned Cold Plasma medical device manufacturer globally, celebrates the establishment of the business as a separate entity on Thursday 1stJune 2023.
  • LONDON, June 1, 2023 /PRNewswire/ -- Adtec Healthcare Limited , originally part of the European subsidiary of its parent company Adtec Technology Japan, was the first company worldwide to introduce Cold Plasma on wounds in clinical trials.
  • Adtec Healthcare's demonstration of the strong clinical benefit of microwave-powered Cold Plasma for the management of infections in chronic wounds, has paved the way for further Cold Plasma research on additional clinical applications.
  • Adtec Healthcare offers its thanks and praises to Adtec Technology Japan for its continued financial support and guidance which without whom they would not be the leading Cold Plasma company they are today.

Stellarator Fusion Company, Type One Energy Group, Raises $29 Million in First Financing, Appointing Christofer Mowry as CEO

Retrieved on: 
Tuesday, March 28, 2023
Technology, Research, Other Energy, Utilities, Other Technology, Energy, Nuclear, Other Science, Science, Breakthrough Energy, Field line, University, Senior advisor, General Fusion, Multimedia, HTS, MIT, Plasma (physics), MIT Plasma Science and Fusion Center, Government, University of Wisconsin–Madison School of Education, BEV, Plasma, The Type One Super Robot, Physics, Knowledge, Mowry, Max Planck Institute for Plasma Physics, Investment, Max Planck Society, Massachusetts Institute of Technology School of Science, Renewable energy, Lithium, Management

This effort launches the company’s ambitious, partner-rich and capital-efficient FusionDirect program to commercialize its stellarator fusion technology.

Key Points: 
  • This effort launches the company’s ambitious, partner-rich and capital-efficient FusionDirect program to commercialize its stellarator fusion technology.
  • Their FusionDirect program sets the path to directly commercialize scientifically mature stellarator technology without the need for a large proof-of-concept prototype.
  • The company’s unique FusionDirect commercialization program takes advantage of recent important breakthroughs to pursue a lowest-risk, shortest-schedule pathway to fusion energy.
  • Among several startups that we have evaluated, Type One Energy is on a credible accelerated trajectory to commercialize a steady-state baseload fusion power plant.

Award-Winning Perricone MD Cold Plasma Plus+ Collection Expands With Two New Skincare Solutions

Retrieved on: 
Tuesday, February 7, 2023
Science, Woman, Trial of the century, Lip, Plasma (physics), Skin, Peptide, Nicotinamide, Dicarboxylic acid, Hyaluronic acid, Collection, Cosmetics, Birth control, Essence

SAN FRANCISCO, Feb. 7, 2023 /PRNewswire/ -- Perricone MD, the brand that is globally celebrated for its relentless pursuit of science-driven skincare, announces new additions to their multi-tasking powerhouse Cold Plasma Plus+ Collection, The Essence and Lip Therapy. These new treatments utilize Perricone MD's proprietary liquid crystal delivery system for faster and deeper penetration of key ingredients into the skin's surface to deliver results you can visibly see. 

Key Points: 
  • Formulated With Proven and Potent Cold Plasma Plus+ Sciences for Healthy, Youthful-Looking Skin
    SAN FRANCISCO, Feb. 7, 2023 /PRNewswire/ -- Perricone MD, the brand that is globally celebrated for its relentless pursuit of science-driven skincare, announces new additions to their multi-tasking powerhouse Cold Plasma Plus+ Collection, The Essence and Lip Therapy.
  • Cold Plasma Plus+ The Essence is a lightweight, fast-absorbing treatment that intensely hydrates and balances, leaving skin looking and feeling smooth and revitalized with a youthful radiance.
  • This powerful essence features amplified levels of the proven Cold Plasma Plus+ sciences for transformative results in only 28 days.
  • "The Cold Plasma Plus+ Collection is our best-selling franchise, for good reason," says Robert Koerner, President of Perricone MD.

Riverside Research Wins 5-Year, $49.5M AFRL MESA II Contract

Retrieved on: 
Friday, December 9, 2022
Physics, Activity, OIC, Object, Intelligence, Development, Plasma, Commercial, United States Department of Defense, Research, Innovation Center station, Air Force Research Laboratory, Intelligence community, AFRL, Computational electromagnetics, Plasma (physics), National security, SLAC National Accelerator Laboratory, Open Architecture Network, PNT, Multimedia, MESA, System integration, Nondestructive testing, Intelligence collection plan, Medical device, Renewable energy, Engineering

WASHINGTON, Dec. 8, 2022 /PRNewswire/ -- Riverside Research, an independent nonprofit national security company, announces win of the Air Force Research Laboratory (AFRL) Microelectronics and Embedded System Assurance (MESA) II Research and Development contract.

Key Points: 
  • WASHINGTON, Dec. 8, 2022 /PRNewswire/ -- Riverside Research, an independent nonprofit national security company, announces win of the Air Force Research Laboratory (AFRL) Microelectronics and Embedded System Assurance (MESA) II Research and Development contract.
  • The$49.5M, five-year contract allows Riverside Research to continue its breakthrough research and long-standing technical leadership in this critical mission area.
  • "We are honored to continue our support for advancing scientific research in support of AFRL and our national security missions," said Riverside Research Vice President, Engineering and Systems Integration, Mary Barefoot.
  • This contract enables Riverside Research to continue supporting AFRL in its advancement of technologies for the warfighter.

Riverside Research Welcomes Chief Human Resources Officer Madelyne D'Angelo

Retrieved on: 
Monday, November 28, 2022
Stratis, Business, Physics, New York City Human Resources Administration, Slippery Rock University of Pennsylvania, Open Architecture Network, Duquesne University, Nondestructive testing, Multimedia, Intelligence, Intelligence community, Government, Activity, Operation, Innovation Center station, Computational electromagnetics, Research, SOSI, Accelerated Christian Education, National security, Dragon Age: Inquisition, Object, Plasma, Commercial, Intelligence collection plan, Equity, United States Department of Defense, Human resources, OIC, CHRO, Plasma (physics), DEI, Management, Science

WASHINGTON, Nov. 28, 2022 /PRNewswire/ -- Riverside Research welcomes Madelyne D'Angelo as the company's Chief Human Resources Officer (CHRO).

Key Points: 
  • WASHINGTON, Nov. 28, 2022 /PRNewswire/ -- Riverside Research welcomes Madelyne D'Angelo as the company's Chief Human Resources Officer (CHRO).
  • D'Angelo brings a combination of significant human resources and operations experience.
  • Invested in enmeshing best HR practices in company growth, D'Angelo's past roles include CHRO at SOS International LLC (SOSi), Vice President of Operations at InquisIT, Vice President, Human Resources at CRGT, and Vice President, Human Resources Administration at L-3 Stratis.
  • "Madelyne brings a unique background and proven skillset to the CHRO role at Riverside.

Timothy Waltz Becomes New Vice President, Sensors & Systems at Riverside Research

Retrieved on: 
Friday, September 30, 2022
Zero, AI accelerator, Workforce, United States Department of Defense, Intelligence community, Navy, Intelligence collection plan, Research, Object, Computational electromagnetics, Waltz, Activity, Plasma, Intelligence, Environment, Open Architecture Network, CEO, National, Technology, Plasma (physics), Physics, Innovation Center station, Commercial, Nondestructive testing, National security, OIC, Multimedia, View, Management, Industrial design

WASHINGTON, Sept. 30, 2022 /PRNewswire/ -- Riverside Research welcomes Timothy Waltz as the new Vice President of its Sensors and Systems Business Unit.

Key Points: 
  • WASHINGTON, Sept. 30, 2022 /PRNewswire/ -- Riverside Research welcomes Timothy Waltz as the new Vice President of its Sensors and Systems Business Unit.
  • "I'm excited to bring Tim onto the team," said Dr. Steven Omick, President and CEO of Riverside Research.
  • Waltz has an illustrative career leading up to his role at Riverside Research.
  • A Navy veteran, he comes to Riverside Research having spent his industry career in research, development, and operations.

TAE Technologies Announces Appointment of Chief Science Officer to International Union of Pure and Applied Physics

Retrieved on: 
Tuesday, March 22, 2022
Other Energy, Utilities, Environment, Alternative Energy, Energy, Technology, Nuclear, Semiconductor, University of California, Irvine School of Physical Sciences, UCI, European Organization for Quality, Astronomy, TAE, Plasma, Sustainable Development Goals, UN, International union, Climate change, National, Multimedia, Secondary research, International Committee for the Nanking Safety Zone, United States national laboratories, UNESCO, Commission, Goal, Hannes Alfvén Prize, CSO, International Center, Enrico Fermi Prize, CERN, Gravitational Wave International Committee, United, TAE Technologies, Nishina Memorial Prize, Sustainable development, Technology, Infection, Norman Rostoker, Knowledge, Laser, Doctor of Philosophy, List of minor secular observances, UN General Assembly Resolution 60/147, Engineering, Plasma (physics), Nature, Tajima, Blaise Pascal, University, Book, Lithium, Renewable energy, Physics, IUPAP

TAE Technologies , the worlds leading developer of clean fusion, is pleased to announce the appointment of Chief Science Officer (CSO) Dr. Toshi Tajima to the International Union of Pure and Applied Physics (IUPAP ) Commission 16 on Plasma Physics.

Key Points: 
  • TAE Technologies , the worlds leading developer of clean fusion, is pleased to announce the appointment of Chief Science Officer (CSO) Dr. Toshi Tajima to the International Union of Pure and Applied Physics (IUPAP ) Commission 16 on Plasma Physics.
  • View the full release here: https://www.businesswire.com/news/home/20220322005147/en/
    Dr. Toshi Tajima, Chief Science Officer, TAE Technologies, has been appointed to the International Union of Pure and Applied Physics (IUPAP) Commission 16 on Plasma Physics.
  • Tajima will serve a four-year term on the Commission, which specializes in the field of plasma physics for applications such as fusion energy.
  • TAE Technologies (pronounced T-A-E) was founded in 1998 to develop commercial fusion power with the cleanest environmental profile.

TAE TECHNOLOGIES ANNOUNCES APPOINTMENT OF CHIEF SCIENCE OFFICER TO INTERNATIONAL UNION OF PURE AND APPLIED PHYSICS

Retrieved on: 
Tuesday, March 22, 2022
University of California, Irvine School of Physical Sciences, UCI, European Organization for Quality, Astronomy, TAE, Plasma, Sustainable Development Goals, UN, International union, Climate change, National, Multimedia, Secondary research, International Committee for the Nanking Safety Zone, United States national laboratories, UNESCO, Goal, Commission, Hannes Alfvén Prize, CSO, CERN, Gravitational Wave International Committee, TAE Technologies, Nishina Memorial Prize, Sustainable development, Technology, Infection, Norman Rostoker, Knowledge, International Center, Laser, Enrico Fermi Prize, Doctor of Philosophy, List of minor secular observances, United Nations, UN General Assembly Resolution 60/147, Engineering, Plasma (physics), Nature, Tajima, Blaise Pascal, University, Book, Lithium, Renewable energy, Physics, IUPAP

LAKE FOREST, Calif., March 22, 2022 /PRNewswire/ -- TAE Technologies, the world's leading developer of clean fusion, is pleased to announce the appointment of Chief Science Officer (CSO) Dr. Toshi Tajima to the International Union of Pure and Applied Physics (IUPAP) Commission 16 on Plasma Physics. 

Key Points: 
  • LAKE FOREST, Calif., March 22, 2022 /PRNewswire/ -- TAE Technologies , the world's leading developer of clean fusion, is pleased to announce the appointment of Chief Science Officer (CSO) Dr. Toshi Tajima to the International Union of Pure and Applied Physics (IUPAP ) Commission 16 on Plasma Physics.
  • Tajima will serve a four-year term on the Commission, which specializes in the field of plasma physics for applications such as fusion energy.
  • TAE Technologies (pronounced T-A-E) was founded in 1998 to develop commercial fusion power with the cleanest environmental profile.
  • Multidisciplinary and mission-driven by nature, TAE is leveraging proprietary science and engineering to create a bright future.